| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |